Clinical Oral Investigations · 2006 · 90 citations · 41 references
MedicineBioengineeringBiomedical EngineeringBiomaterialsBone GraftingBone MetabolismBone Graft SubstitutesBone RegenerationBone SubstitutesBone Tissue EngineeringImplantable BiomaterialsOsteogenesisBone Density EstimationBone Formation IndicesBone Formation MarkersBone Regeneration MaterialsPilot Study DesignTissue AppositionTitanium MaterialsTitanium Surface Modification
The aim of the present study was to investigate bone formation to recombinant human bone morphogenetic protein-2 (rhBMP-2)-biocoated and rhBMP-2-nonbiocoated titanium implants after implantation in dogs. Implantation of sand-blasted and acid-etched (C), chromosulfuric acid surface-enhanced (CSA), and rhBMP-2-biocoated CSA [BMP-A: noncovalently immobilized rhBMP-2 (596 ng/cm(2)), BMP-B: covalently immobilized rhBMP-2 (819 ng/cm(2))] implants was performed in both the mandible and tibia of dogs. After 4 weeks of healing, the percentage of direct bone to implant contact (BIC) and the induced bone density (BD) at a distance of less than and greater than 1 mm adjacent to each implant was assessed. Histomorphometric analysis of implants inserted in the mandible and tibia revealed that BIC values appeared to be highest in the BMP-B group, followed by BMP-A, CSA, and C. BD as measured at a distance of <1 mm revealed obvious differences between groups: BMP-B>BMP-A>CSA>C. However, no differences between groups were observed at a distance of >1 mm. Within the limits of the present study, it may be concluded that rhBMP-2 immobilized by covalent and noncovalent methods on CSA-treated implant surfaces seemed to be stable and promoted direct bone apposition in a concentration-dependent manner.
41
Bone Cell Differentiation and Growth Factors
Marshall R. Urist, Robert J. DeLange, Gerald A. M. Finerman · Science · 1983 · 876 citations
Xuezhong Qin, Reinhard Gysin, Subburaman Mohan et al. · Elsevier eBooks · 2001 · 471 citations